What’s So Great About STAR*D?

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Treatment for depression costs the United States a staggering $83 billion each year. Part of this is due to the fact that the treatments themselves involve so much trial and error; there’s very little reliable information out on the effectiveness of various drugs and forms of therapy.

So it’s good news that today Slate is reporting on a new study called STAR*D, conducted by the National Institute of Mental Health, that compares and contrasts the twenty options for prescription antidepressants, their dosages, and even the effects of psychotherapy — something no other study has ever done. For the 19 million Americans who suffer from depression, this is a major step forward. The pharmaceutical industry usually doesn’t produce any comparative data on depression, a state of affairs that has previously left most patients and their doctors guessing which treatment will be the best fit.

Comparative, independent trials will also enable doctors to rely less on collected by the pharmaceutical industry. Mark Gibson, deputy director of the Center for Evidence-Based Policy at Oregon Health and Science University, adds that in regards to data provided by drug firms, “it’s not unusual for less than 10 percent of studies to meet our standards of quality.” And according to Jerry Avorn, professor of medicine at Harvard, comparative studies could motivate drug companies to develop more advanced versions of current drugs, improving on what we already have.

GREAT JOURNALISM, SLOW FUNDRAISING

Our team has been on fire lately—publishing sweeping, one-of-a-kind investigations, ambitious, groundbreaking projects, and even releasing “the holy shit documentary of the year.” And that’s on top of protecting free and fair elections and standing up to bullies and BS when others in the media don’t.

Yet, we just came up pretty short on our first big fundraising campaign since Mother Jones and the Center for Investigative Reporting joined forces.

So, two things:

1) If you value the journalism we do but haven’t pitched in over the last few months, please consider doing so now—we urgently need a lot of help to make up for lost ground.

2) If you’re not ready to donate but you’re interested enough in our work to be reading this, please consider signing up for our free Mother Jones Daily newsletter to get to know us and our reporting better. Maybe once you do, you’ll see it’s something worth supporting.

payment methods

GREAT JOURNALISM, SLOW FUNDRAISING

Our team has been on fire lately—publishing sweeping, one-of-a-kind investigations, ambitious, groundbreaking projects, and even releasing “the holy shit documentary of the year.” And that’s on top of protecting free and fair elections and standing up to bullies and BS when others in the media don’t.

Yet, we just came up pretty short on our first big fundraising campaign since Mother Jones and the Center for Investigative Reporting joined forces.

So, two things:

1) If you value the journalism we do but haven’t pitched in over the last few months, please consider doing so now—we urgently need a lot of help to make up for lost ground.

2) If you’re not ready to donate but you’re interested enough in our work to be reading this, please consider signing up for our free Mother Jones Daily newsletter to get to know us and our reporting better. Maybe once you do, you’ll see it’s something worth supporting.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate